Clinical Trials Browser

NCT05615142 2026-05-11

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

Phase 1 Active not recruiting

9 enrolled

Thoracic

NSCLC

NCT07541755 2026-04-21

PD1-VEN-CAG

Phase 3 Active not recruiting

40 enrolled

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07428252 2026-02-25

Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma

Phase NA Active not recruiting

150 enrolled

Dermatologic

Melanoma

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Phase EARLY_PHASE1 Active not recruiting

22 enrolled

Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT05621707 2026-02-02

RICE

Phase 2 Active not recruiting

50 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06710847 2026-02-02

SYLVER

Phase 1/2 Active not recruiting

14 enrolled

GastrointestinalGynecologic

Turcot syndrome, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07339488 2026-01-14

ILDR-03

Phase 2 Active not recruiting

43 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05013450 2025-12-17

Dupilumab_Metastatic NSCLC

Phase 1/2 Active not recruiting

33 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05241340 2025-10-24

RAD-VACCINE

Phase 2 Active not recruiting

33 enrolled

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT04225039 2025-08-15

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Phase 2 Active not recruiting

39 enrolled 10 charts

CNS

Glioblastoma

NCT04907370 2025-07-16

DIAMOND

Phase 3 Active not recruiting

532 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06076135 2025-06-15

ILDR-01

Phase 2 Active not recruiting

16 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT05704985 2025-05-29

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Phase 1 Active not recruiting

39 enrolled

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Neoplasms, Pancreatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

NCT04836728 2025-03-13

CCICC-002b

Phase 2 Active not recruiting

156 enrolled

Thoracic

Non-small Cell Lung Cancer Metastatic

NCT05491616 2025-02-13

SANO-3

Phase 2 Active not recruiting

77 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06700421 2024-11-22

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Phase 2 Active not recruiting

32 enrolled

Radiation Pneumonitis

NCT06026254 2024-11-18

A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial

Phase 1 Active not recruiting

2 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05522582 2024-10-26

Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors

Phase 2 Active not recruiting

50 enrolled

Other solid neoplasm

Solid Tumors

NCT04230759 2024-09-19

RADIANCE

Phase 2 Active not recruiting

180 enrolled

Gastrointestinal

Anus Neoplasms

NCT04715633 2024-07-09

PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer

Phase 2 Active not recruiting

53 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04891900 2024-07-08

TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma

Phase NA Active not recruiting

25 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06342167 2024-06-11

Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma

Phase 2 Active not recruiting

57 enrolled

Gastrointestinal

Locally Advanced Esophageal Squamous Cell Carcinoma